Need help? Our team of experienced experts is here for you with full support.
AKA-231
Rapamycin
Cat. No.
AKA-231
CAS No.
53123-88-9
MF
C51H79NO13
MW
914.17
Rapamycin is a potent and specific mTOR inhibitor.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Data
Description
Documents
Storage and Shipping
References
Product Name
Rapamycin
CAS No.
53123-88-9
MF
C51H79NO13
MW
914.17
Specification
98%
Research Area
mTOR inhibitor
Description
Rapamycin is a potent and specific mTOR inhibitor. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g Availability: In stock
Documents
Can't find the right version? Our team of experienced experts is here for you with full support.Contact Us
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. Svensson JE, et al. Evaluating the effect of rapamycin treatment in Alzheimer's disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol. BMC Neurology. 2024 Apr 4;24(1):111.
[2]. Soini L, et al. Molecular glues to stabilise protein-protein interactions. Current Opinion in Chemical Biology. 2022 Aug;69:102169.
[3]. Edwards SR, et al. The rapamycin-binding domain of the protein kinase mammalian target of rapamycin is a destabilizing domain. The Journal of Biological Chemistry. 2007;282(18):13395-13401.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.